Pulmo BioTech, Inc. (PLMO.OB) is “One to Watch”
Pulmo BioTech, Inc is dedicated to bringing revolutionary medical diagnostic technologies to the market. The company’s current product base is composed of an array of molecular imaging substances developed for the diagnosis of pulmonary embolism, pulmonary hypertension, and lung inflammatory disorders. Presently, these substances are in the process of receiving regulatory approval before entering Phase I human trials. The company has used the brand name “PulmoBind” for these substances. These products have the potential to completely replace the conventional technology being used for a nuclear medicine-based diagnosis of pulmonary embolism. The substances could also create new markets for the diagnosis…